Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FGF23 response in hypophosphatemia
2016-002602-39Phase 4Active
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lanthanum carbonate, sponsored by Radboud University Medical Center. Started Jul 2016; status: active.
02
Drugs
lanthanum carbonate
Beyond the preview
Go deeper on 2016-002602-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002602-39.